It is also noteworthy that similar white matter abnormalities have been linked to Alzheimer’s disease [114], suggesting that mTOR/mTORC targeted therapeutic interventions may benefit other neurodegenerative diseases in which white matter degeneration is a dominant feature. This evidence concerns the gene MTOR and Alzheimer disease.